Personalized Medicine's Skeptics.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 139
- By:
- Publication type:
- Article
Works matching IS 21660166 AND DT 2016 AND VI 5 AND IP 3
Results: 17
1
2
Biomarker for Uveal Melanoma Has Immediate Clinical Impact.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 138
- By:
- Publication type:
- Article
3
Stem Cell Inhibitor Active in Pancreatic Cancer, CRC.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 137
- Publication type:
- Article
4
A Role for Intralesional Monotherapy in Melanoma: Debate.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 129
- By:
- Publication type:
- Article
5
Secondary Pathology Review Improves Clinical Outcomes.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 136
- Publication type:
- Article
6
Improving Value by Understanding Total Cost of Cancer Care.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 134
- By:
- Publication type:
- Article
7
How Do We Measure Quality in the Age of Precision Medicine?
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 133
- Publication type:
- Article
8
RECQL and Breast Cancer Risk.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 128
- By:
- Publication type:
- Article
9
Data Drive Quality Improvement in an Oncology Patient-Centered Medical Home.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 132
- By:
- Publication type:
- Article
10
Combination Checkpoint Blockade-- It Is the New Standard for All Patients.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 130
- By:
- Publication type:
- Article
11
AGENDA.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 111
- Publication type:
- Article
12
Checkpoint Inhibition: A Promising Immunotherapeutic Approach for Colorectal Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 124
- Publication type:
- Article
13
Prolonged Survival of a Patient with Relapsed, Metastatic, SPARC-Overexpressed Lung Adenocarcinoma Treated with Low- Dose nab-Paclitaxel.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 120
- By:
- Publication type:
- Article
14
The Rebirth of Ex Vivo Cell Screening for Clinical Use.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 117
- By:
- Publication type:
- Article
15
State of Personalized Medicine in Breast Cancer.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 112
- By:
- Publication type:
- Article
16
NCI-MATCH: A Paradigm Shift in the Evolution of Personalized Medicine Trials.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 105
- Publication type:
- Article
17
Making Strides in Personalizing Medicine.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 104
- By:
- Publication type:
- Article